Reaction Details Report a problem with these data
Target
Large envelope protein
Ligand
BDBM576317
Substrate
n/a
Meas. Tech.
PHH Natural Infection Assay
IC50
570±n/a nM
Citation
 Xianfeng, L; Hongying, Y; Bo, Z; Xiufang, Z ARYLOXAZOLO SPIRAL RING DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION WIPO WO2022112140 Publication Date -1/2/2022 
Target
Name:
Large envelope protein
Synonyms:
HBSAG_HBVD3 | S
Type:
n/a
Mol. Mass.:
42772.52
Organism:
HBV-D
Description:
P03138
Residue:
389
Sequence:
MGQNLSTSNPLGFFPDHQLDPAFRANTANPDWDFNPNKDTWPDANKVGAGAFGLGFTPPHGGLLGWSPQAQGILQTLPANPPPASTNRQSGRQPTPLSPPLRNTHPQAMQWNSTTFHQTLQDPRVRGLYFPAGGSSSGTVNPVLTTASPLSSIFSRIGDPALNMENITSGFLGPLLVLQAGFFLLTRILTIPQSLDSWWTSLNFLGGTTVCLGQNSQSPTSNHSPTSCPPTCPGYRWMCLRRFIIFLFILLLCLIFLLVLLDYQGMLPVCPLIPGSSTTSTGPCRTCMTTAQGTSMYPSCCCTKPSDGNCTCIPIPSSWAFGKFLWEWASARFSWLSLLVPFVQWFVGLSPTVWLSVIWMMWYWGPSLYSILSPFLPLLPIFFCLWVYI
  
Inhibitor
Name:
BDBM576317
Synonyms:
WO2022112140, Example 23
Type:
Small organic molecule
Emp. Form.:
C21H20ClN3O4S
Mol. Mass.:
445.919
SMILES:
n/a
Structure:
Search PDB for entries with ligand similarity: